Mutant p53 drives cancer by subverting multiple tumour suppression pathways
The tumour suppressor p53 normally acts as a brake to halt damaged cells from perpetrating their genetic errors into future generations. If p53 is disrupted by mutation, it may not only lose these corrective powers, but counter-productively acquire new capacities that drive cancer. A newly emerging...
Main Authors: | Sue eHaupt, Dinesh eRaghu, Ygal eHaupt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00012/full |
Similar Items
-
P53 calls upon CIA (Calcium Induced Apoptosis) to counter stress
by: Ygal eHaupt, et al.
Published: (2015-03-01) -
Regulation of Mutant p53 protein expression
by: Reshma eVijayakumaran, et al.
Published: (2015-12-01) -
Editorial: Human tumor-derived p53 mutants: a growing family of oncoproteins
by: Ygal Haupt, et al.
Published: (2016-07-01) -
Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity
by: Sue Haupt, et al.
Published: (2021-02-01) -
New strategies to direct therapeutic targeting of PML to treat cancers
by: Kamil eWolyniec, et al.
Published: (2013-05-01)